Viewing Study NCT06426732



Ignite Creation Date: 2024-06-16 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06426732
Status: RECRUITING
Last Update Posted: 2024-05-23
First Post: 2024-05-18

Brief Title: The Trajectory of Blood Pressure During Pregnancy in Assisted Reproductive Females
Sponsor: The Second Hospital of Shandong University
Organization: The Second Hospital of Shandong University

Study Overview

Official Title: The Trajectory of Blood Pressure During Pregnancy in Assisted Reproductive Females
Status: RECRUITING
Status Verified Date: 2024-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The incidence of gestational hypertension and preeclampsia in the assisted reproductive technology population during pregnancy was significantly higher than that in the general normal pregnancy population The use of assisted reproductive technology in this population due to infertility is often accompanied by many hypertension-related factors We established a prospective cohort study based on assisted reproductive technology pregnancy population and natural pregnancy population Through continuous monitoring of blood pressure changes and other risk factors during pregnancy in the two groups we explored the trajectory trend and inflection point of assisted reproductive technology pregnancy population blood pressure during pregnancy Through factor analysis the risk factors of elevated blood pressure during pregnancy can be clearly identified so as to carry out early intervention and strengthen the control of risk factors of elevated blood pressure in assisted reproductive technology population in order to expect benign maternal and infant outcomes
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None